PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape
AUAUniversity31 Mars 2021

PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape

This educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31198 Based on the documented need from the 2019 AUA global needs assessment in advanced prostate cancer, the AUA has produced a new series of educational offerings for the urologic care team focused on PARP inhibitors (PARPi). The first of three in the series PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape will address the latest developments in PARPi treatments and advanced prostate cancer care. Upon completion of this activity, participants will be able to: 1. Review recommended criteria for genetic testing of prostate cancer patients and the options for testing these men. 2. Explain importance of testing for germline pathogenic variants and their implication for utilizing novel targeted therapies such as PARP inhibitors and for cascade testing among patient family members. 3. Identify men with BRCA1/2 pathogenic variants and variants in other key inherited syndromes, regarding their prostate cancer and other cancer risk, and implement strategies for cancer screening and management.

Avsnitt(426)

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24584 Instructional Course Director(s) Eric Rovner, MD Medical...

27 Juni 20191h 54min

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

20 Juni 20191h 44min

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

14 Juni 20192h 1min

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

6 Juni 20191h 49min

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24581 Instructional Course Director(s) Kathleen Kobashi, MD, F...

30 Maj 20191h 58min

AUA2019 013IC Genetic Testing In Prostate Cancer

AUA2019 013IC Genetic Testing In Prostate Cancer

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

21 Maj 20191h 57min

Live From AUA2019 Management Of Advanced And Metastatic Urothelial Carcinoma

Live From AUA2019 Management Of Advanced And Metastatic Urothelial Carcinoma

This educational activity is supported by independent educational grants from: Astellas, Merck and Seattle Genetics CME Available: https://auau.auanet.org/node/24777 In this unique presentation, pan...

16 Maj 201955min

Live From AUA2019 Management Of Non - Muscle Invasive Urothelial Carcinoma

Live From AUA2019 Management Of Non - Muscle Invasive Urothelial Carcinoma

This educational activity is supported by independent educational grants from: Astellas, Merck and Seattle Genetics CME Available: https://auau.auanet.org/node/24288 In this unique presentation, pan...

8 Maj 201951min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
alska-oss
harrisons-dramatiska-historia
nu-blir-det-historia
not-fanny-anymore
johannes-hansen-podcast
roda-vita-rosen
sektledare
allt-du-velat-veta
rss-viktmedicinpodden
i-vantan-pa-katastrofen
sa-in-i-sjalen
rss-max-tant-med-max-villman
rss-sjalsligt-avkladd
rss-basta-livet
rss-om-vi-ska-vara-arliga
sex-pa-riktigt-med-marika-smith
rss-pa-insidan-med-bjorn-rudman